Stock Events

Stock Events

Cadrenal Therapeutics (CVKD) Q2 2026 Earnings

May 7Confirmed

Q2 2025

Q3 2025

Q4 2025

Q2 2026

-2.15

-1.78

-1.41

-1.04

Details

Expected EPS

-1.51

Actual EPS

-1.04

Surprise EPS

0.47

Surprise Percent

+31.13%

Description

⁨Cadrenal Therapeutics⁩ (⁦CVKD⁩) has reported earnings of ⁦-1.04⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.